OBJECTIVE: Health-promoting behaviors are recommended to childhood cancer survivors (CCS) to reduce late effects resulting from cancer treatment. Understanding factors associated with substance use is needed, especially among Hispanic CCS who are underrepresented in previous studies. The objective of this study is to examine substance use behaviors of recently treated Hispanic and non-Hispanic CCS. METHODS: One hundred ninety-three Los Angeles County CCS who were diagnosed between 2000 and 2007 (54% Hispanic; mean age 19.9 years, SD = 2.8; mean age at diagnosis = 12.1, SD = 3.0; mean years since diagnosis = 7.8, SD = 2.0) provided self-reported information on substance use, demographics, clinical factors, religiosity, and depressive symptoms. Risk and protective factors for substance use were examined using multivariable logistic regression. RESULTS: Prevalence of 30-day substance use was 11%, 25%, and 14% for tobacco, alcohol, and marijuana, respectively. In controlled regression models, age was positively associated with tobacco use, binge drinking, and polysubstance use (use of at least two of the three substances). Male gender, higher depressive symptoms, and higher socioeconomic status were associated with greater marijuana use. In addition, religiosity was negatively associated with the use of all substances. CONCLUSIONS: The prevalence rates for substance use in this ethnically diverse representative sample of CCS are lower than those observed in the general population. Older CCS were at higher risk of substance use, and depression was associated with greater marijuana use. No differences by ethnicity were observed. Interventions for substance use prevention/cessation among CCS may be most effective if implemented before the age of 21 years and address mental health as part of survivorship care.
OBJECTIVE: Health-promoting behaviors are recommended to childhood cancer survivors (CCS) to reduce late effects resulting from cancer treatment. Understanding factors associated with substance use is needed, especially among Hispanic CCS who are underrepresented in previous studies. The objective of this study is to examine substance use behaviors of recently treated Hispanic and non-Hispanic CCS. METHODS: One hundred ninety-three Los Angeles County CCS who were diagnosed between 2000 and 2007 (54% Hispanic; mean age 19.9 years, SD = 2.8; mean age at diagnosis = 12.1, SD = 3.0; mean years since diagnosis = 7.8, SD = 2.0) provided self-reported information on substance use, demographics, clinical factors, religiosity, and depressive symptoms. Risk and protective factors for substance use were examined using multivariable logistic regression. RESULTS: Prevalence of 30-day substance use was 11%, 25%, and 14% for tobacco, alcohol, and marijuana, respectively. In controlled regression models, age was positively associated with tobacco use, binge drinking, and polysubstance use (use of at least two of the three substances). Male gender, higher depressive symptoms, and higher socioeconomic status were associated with greater marijuana use. In addition, religiosity was negatively associated with the use of all substances. CONCLUSIONS: The prevalence rates for substance use in this ethnically diverse representative sample of CCS are lower than those observed in the general population. Older CCS were at higher risk of substance use, and depression was associated with greater marijuana use. No differences by ethnicity were observed. Interventions for substance use prevention/cessation among CCS may be most effective if implemented before the age of 21 years and address mental health as part of survivorship care.
Authors: Arnie Cann; Lawrence G Calhoun; Richard G Tedeschi; Kanako Taku; Tanya Vishnevsky; Kelli N Triplett; Suzanne C Danhauer Journal: Anxiety Stress Coping Date: 2010
Authors: Laura Kann; Steve Kinchen; Shari L Shanklin; Katherine H Flint; Joseph Kawkins; William A Harris; Richard Lowry; Emily O'Malley Olsen; Tim McManus; David Chyen; Lisa Whittle; Eboni Taylor; Zewditu Demissie; Nancy Brener; Jemekia Thornton; John Moore; Stephanie Zaza Journal: MMWR Suppl Date: 2014-06-13
Authors: Karen Emmons; Frederick P Li; John Whitton; Ann C Mertens; Raymond Hutchinson; Lisa Diller; Leslie L Robison Journal: J Clin Oncol Date: 2002-03-15 Impact factor: 50.717
Authors: Linda C Harlan; Charles F Lynch; Theresa H M Keegan; Ann S Hamilton; Xiao-Cheng Wu; Ikuko Kato; Michele M West; Rosemary D Cress; Stephen M Schwartz; Ashley W Smith; Dennis Deapen; Sonja M Stringer; Arnold L Potosky Journal: J Cancer Surviv Date: 2011-01-28 Impact factor: 4.442
Authors: Karen M Emmons; Elaine Puleo; Kim Sprunck-Harrild; Jennifer Ford; Jamie S Ostroff; David Hodgson; Mark Greenberg; Lisa Diller; Janet de Moor; Vida Tyc Journal: J Med Internet Res Date: 2013-11-05 Impact factor: 5.428
Authors: Joel Milam; Rhona Slaughter; Jessica L Tobin; Jennifer B Unger; Anamara Ritt-Olson; David R Freyer; Daniel Soto; Ann S Hamilton Journal: J Adolesc Health Date: 2018-07 Impact factor: 5.012
Authors: Katie Darabos; Lamia P Barakat; Marilyn Schapira; Christine Hill-Kayser; Lisa A Schwartz Journal: J Adolesc Young Adult Oncol Date: 2020-11-18 Impact factor: 2.223
Authors: Stephanie B Dixon; Kari L Bjornard; Nicole M Alberts; Gregory T Armstrong; Tara M Brinkman; Wassim Chemaitilly; Matthew J Ehrhardt; Israel Fernandez-Pineda; Lisa M Force; Todd M Gibson; Daniel M Green; Carrie R Howell; Sue C Kaste; Anne C Kirchhoff; James L Klosky; Kevin R Krull; John T Lucas; Daniel A Mulrooney; Kirsten K Ness; Carmen L Wilson; Yutaka Yasui; Leslie L Robison; Melissa M Hudson Journal: CA Cancer J Clin Date: 2018-01-29 Impact factor: 508.702
Authors: Jessica L Tobin; Stefanie M Thomas; David R Freyer; Ann S Hamilton; Joel E Milam Journal: Cancer Causes Control Date: 2020-08-05 Impact factor: 2.532
Authors: Billy Vinette; José Côté; Ali El-Akhras; Hazar Mrad; Gabrielle Chicoine; Karine Bilodeau Journal: BMC Cancer Date: 2022-03-24 Impact factor: 4.430